利用CRISPR/Cas9技术构建ALK7LoxP/LoxP小鼠品系
DOI:
作者:
作者单位:

(1.青岛大学附属青岛市市立医院心内科,山东省青岛市 266000;2.山东大学齐鲁医院重症医学科, 山东省济南市 250012;3.山东大学齐鲁医院急诊科,山东省济南市 250012)

作者简介:

赵强,硕士研究生,研究方向为心血管疾病与动脉粥样硬化,E-mail为ZhaoQiangDoc@163.com。通信作者管军,博士,主任医师,博士研究生导师,研究方向为冠心病的诊断及介入治疗, E-mail为guanjun@medmail.com.cn。

通讯作者:

基金项目:

国家自然科学基金项目(81670411)


Establishment of ALK7LoxP/LoxP mouse by CRISPR/Cas9
Author:
Affiliation:

1.Department of Cardiology, Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 260000;2.ICU, Qilu Hospital of Shandong University, Jinan, Shandong 250012;3.Department of Emergency, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 利用CRISPR/Cas9技术将LoxP序列靶向导入小鼠活化素受体样激酶7(ALK7)基因,构建ALK7LoxP/LoxP小鼠,与组织特异性Cre小鼠杂交,获得时空特异性ALK7基因敲除小鼠,为研究ALK7在特定时间特定组织中的功能奠定基础。方法 利用CRISPR/Cas9技术编辑小鼠ALK7基因:设计合成识别ALK7基因外显子4-6上下游非编码序列的sgRNA。设计并合成LoxP-ALK7-LoxP打靶载体,测序正确后,显微注射法将体外合成的sgRNA、Cas9 mRNA和打靶载体注射到小鼠受精卵,移植受精卵至假孕小鼠输卵管代孕。获得仔鼠后通过PCR、Southern blot鉴定子代小鼠基因型,实时荧光定量PCR、Western blot检测ALK7转录表达水平。 结果 获得了含有目的基因的打靶阳性小鼠,并且插入的LoxP序列不影响ALK7的转录表达水平。结论 利用CRISPR/Cas9技术成功将LoxP序列靶向引入小鼠ALK7基因,成功构建ALK7LoxP/LoxP小鼠品系,为进一步构建组织特异性ALK7基因敲除小鼠模型奠定了基础。

    Abstract:

    Aim To generate mutant mouse with ALK7 gene inserted by LoxP sequences by CRISPR/Cas9, to further develop temperospatial specific ALK7 deleted mouse models via cross bred with the tissue-specific Cre mouse, providing a basis for functional study of ALK7 in special time and tissue. Methods The CRISPR/Cas9 technology was used to edit ALK7. Two sgRNAs were designed to direct Cas9 endonuclease cleavage in intron 3-4 and intron 6-7. The targeting vector with LoxP-ALK7-LoxP sequence was designed. sgRNA, Cas9 mRNA and targeting vector were co-injected into zygotes, which were transferred to pseudopregnant mice. The pups were genotyped by PCR and Southern blott. Real-time PCR and Western blot were performed for analysis of the expression of ALK7. Results The ALK7LoxP/LoxP mouse was generated by CRISPR/Cas9, and did not show influence on the expression of ALK7. Conclusion The CRISPR/Cas9 technology can successfully generate the ALK7LoxP/LoxP mouse by inserting LoxP sequence into ALK7 gene, which is a basis for the creation of tissue-specific ALK7 deleted mouse models.

    参考文献
    相似文献
    引证文献
引用本文

赵强,刘灯泉,李毅辉,戴红艳,唐梦熊,管军.利用CRISPR/Cas9技术构建ALK7LoxP/LoxP小鼠品系[J].中国动脉硬化杂志,2019,27(1):69~74.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2018-08-08
  • 最后修改日期:2018-09-26
  • 录用日期:
  • 在线发布日期: 2019-01-21